Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets

por Jiangnan He, Michelle K.Y. Siu, Hextan Y. S. Ngan, Karen K. L. Chan
Publicado 2021

Increased expression of PITX2 transcription factor contributes to ovarian cancer progression.

por Frederic K C Fung, David W Chan, Vincent W S Liu, Thomas H Y Leung, Annie N Y Cheung, Hextan Y S Ngan
Publicado 2012

Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface

por Maggie K. S. Tang, Patrick Y. K. Yue, Philip P. Ip, Rui-Lan Huang, Hung-Cheng Lai, Annie N. Y. Cheung, Ka Yu Tse, Hextan Y. S. Ngan, Alice S. T. Wong
Publicado 2018

Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.

por Michelle K Y Siu, Daniel S H Kong, Hoi Yan Chan, Esther S Y Wong, Philip P C Ip, LiLi Jiang, Hextan Y S Ngan, Xiao-Feng Le, Annie N Y Cheung
Publicado 2012